Tony Chang, PhD, joined the Merck Ventures Life Science team as an Analyst in November 2016. Prior to this, he was a technology commercialization officer at the University of Western Cape in South Africa where he was responsible for the development of several industry research collaborations and licensing deals. Previously, Tony was a consultant in the strategy practice of EY in Johannesburg. Tony received his PhD in medical biochemistry from the University of Cape Town and is in the process of concluding his MBA at the Rotterdam School of Management. Tony is based in Amsterdam.